Global Soft Tissue Repair Market Trends, Strategies, And Opportunities In The Soft Tissue Repair Market 2021-2030 einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Global
Cardiovascular and Soft Tissue Repair Patches Market would witness significant growth in the coming years and is expected to grow at the rate of substantial compound annual growth rate (CAGR) during the forecast period.The market is expected to grow due to different factors that has been having the major impact combining drivers, restraints and opportunities. The application areas of this industry and its growth in the different geographies are major factors behind the market growth. The report covers the market from almost all the aspects either driving or restraining the market growth. High-end analysis has been provided in the report depending on the factors such as Porter’s five forces analysis, competitive landscape, SWOT and PEST analysis, including the
Global Tissue Repair Technologies Market Tendencies, Revenue Forecast and Interesting Opportunities from 2020 to 2025 texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
CENTER VALLEY, Pa., Jan. 19, 2021 /PRNewswire/ Aesculap has been awarded a contract with Vizient that offers state-of-the-art neurosurgical technology at enhanced savings to Vizient member hospitals. The contract includes Cerebral Spinal Fluid (CSF) Management and Dural Repair and Neuro Critical Care product categories.
Vizient s diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute healthcare providers and represents more than $100 billion in annual purchasing volume.
As a result of the award, Vizient members will now have access to contracted pricing for all of Aesculap s fixed and programmable hydrocephalus shunts, including the new